New drug could reduces the chances of a second heart attack: researchA new drug reduced the risk of dying from a heart attack or other cardiac problem by one fifth compared to the current gold standard drug. The results of a study were presented at the European Society of Cardiology in Barcelona, Spain and were published in the New England Journal of Medicine.

A new drug reduced the risk of dying from a heart attack or other cardiac problem by one fifth compared to the Buy 400 current gold standard drug.

The results of a study were looking presented at the European Society of Cardiology in Barcelona, Spain and were published in legal the New England Journal of Medicine.

Ticagrelor 200 mg prices also reduced the risk of suffering online order a second attack by 16 per cent when compared with clopidogrel, a commonly used anti-clotting drug.

The drug did reviews not increase the risk of bleeding, which is the most serious side effect of anti-clotting drugs.

Dr Robert Storey, lead low cost author and 200 mg dosage honorary consultant in cardiology at Sheffield University said: “These free data show that this new drug has the list potential to save many lives in the UK.

“The results of this trial are hugely medJ exciting in that we see, for the first time, improved efficacy compare without an increased overall risk of life-threatening or fatal bleeding.”

The results mean that for 300 online every 1,000 patients treated for one year with tricagrelor instead of clopidogrel, there would be 14 fewer deaths or 11 fewer heart attacks without an increase in bleeding problems.

Tricagrelor, made by Astra Zeneca, is not yet licensed.

The study, called Plato, involved more than 18,000 patients worldwide including Britain, where 200 mg can i buy cheap patients were randomly assigned to have tricagrelor twice daily with a placebo or clopidogrel plus placebo for a year.

Around cheap 250,000 people in Britain are admitted to hospital with unstable angina or heart attacks and around one in three will have another heart attack, be admitted for a second time or die within six months.

Guy Yeoman, 400 mg Order Medical Director, AstraZeneca shipping UK, said: “The discovery and development of ticagrelor has been an exciting journey for AstraZeneca, building upon our heritage in developing effective cardiovascular where can i buy therapies.

“Ticagrelor works in a different way to other medicines currently available, and had 200 mg Price demonstrated in earlier clinical trials that it has a faster onset of action compared to clopidogrel and a more consistent and predictable response.

“We have now seen online range through the announcement of the Plato results that the earlier positive results have translated into positive outcomes for patients”.

Add a comment August 31, 2009